CHART Revisited: A Conservative Approach for Advanced Head and Neck Cancer

Clinical Oncology

Volumn 20, Issue 2, 2008, Pages 127-133

  Saunders, M ^a,b   Rojas, A M ^b   Dische, S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

CHART; head and neck cancer; long term adverse events; long term outcome; therapeutic gain

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIATION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSPHAGIA; FEMALE; FIBROSIS; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION INJURY; RISK ASSESSMENT; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS TISSUE; SURVIVAL TIME; ULCER; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 39049136038     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.11.001     Document Type: Article

References (35)

1. Al-Othman M.O., Morris C.G., Hinerman R.W., et al. Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 25 8 (2003) 629-633
2. Forastiere A.A. Overview of platinum chemotherapy in head and neck cancer. Semin Oncol 21 5 Suppl 12 (1994) 20-27
3. Suit H.D., and Westgate S.J. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 12 4 (1986) 453-458
4. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 9538 (2006) 843-854
5. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 9208 (2000) 949-955
6. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 19 (2004) 1945-1952
7. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 19 (2004) 1937-1944
8. Ang K.K. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects?. J Clin Oncol 22 23 (2004) 4657-4659
9. Henk J.M. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol) 9 5 (1997) 308-312
10. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47 1 (2000) 1-12
11. Trotti A., and Bentzen S.M. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 22 1 (2004) 19-22
12. Saunders M., and Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol 59 (1986) 523-525
13. Dische S., Warburton M.F., Jones D., and Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol 16 (1989) 103-108
14. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., and Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 2 (1997) 123-136
15. Zackrisson B., Mercke C., Strander H., Wennerberg J., and Cavallin-Stahl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 42 5-6 (2003) 443-461
16. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 1 (2004) 69-76
17. Denis F., Garaud P., Bardet E., et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55 1 (2003) 93-98
18. Bentzen S.M., Dorr W., Anscher M.S., et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol 13 3 (2003) 189-202
19. Ang K.K., Berkey B.A., Pajak T.F., and Fu K.K. In response to Drs. Dubben, Beck-Bornholdt, and Llogie. Int J Radiat Oncol Biol Phys 52 4 (2002) 1148-1150
20. Bourhis J., Lapeyre M., Tortochaux J., et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 24 18 (2006) 2873-2878
21. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44 2 (1997) 111-121
22. Poulsen M.G., Denham J.W., Peters L.J., et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60 2 (2001) 113-122
23. Cummings B., O'Sullivan B., Keane T., et al. 5 year results of a 4 week/twice daily radiation schedule - the Toronto Trial. Radiother Oncol 56 Suppl 1 (2000) S8
24. Fallai C., Bolner A., Signor M., et al. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx. Tumori 92 1 (2006) 41-54
25. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 4 (1992) 231-241
26. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 9388 (2003) 933-940
27. Skladowski K., Maciejewski B., Golen M., et al. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys 66 3 (2006) 706-713
28. Trotti A., Fu K.K., Pajak T.F., et al. Long term outcomes of RTOG 90-03: a comparison of hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 63 2 Suppl 1 (2005) S70-S71
29. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6 9 (2006) 702-713
30. Bernier J., and Bentzen S.M. Radiotherapy for head and neck cancer: latest developments and future perspectives. Curr Opin Oncol 18 3 (2006) 240-246
31. Bourhis J. New approaches to enhance chemotherapy in SCCHN. Ann Oncol 16 Suppl 6 (2005) vi20-vi24
32. Milas L., Mason K.A., Liao Z., and Ang K.K. Chemoradiotherapy: emerging treatment improvement strategies. Head Neck 25 2 (2003) 152-167
33. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 6 (2006) 567-578
34. Bernier J., and Schneider D. Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?. Eur J Cancer 43 1 (2007) 35-45
35. Bentzen S.M., Atasoy B.M., Daley F.M., et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23 24 (2005) 5560-5567